U.S. Hospitals Shift to Safer, Cost-Effective Vascular Access Solutions, Pushing Market to $6.9B by 2031 – iData Research
VANCOUVER, BC, May 14, 2025 /PRNewswire/ - A new 2025 Vascular Access Devices Market Report reveals that the U.S. vascular...
Antimicrobial
Best Skin Tag Remover 2025: Revitag Review & Top Skin Tag Removal Tips
Looking for the best skin tag remover in 2025? Discover how Revitag works, plus expert tips on safe, fast, and...
Digital Wound Management Devices Market to Reach USD 3,594.49 million By 2032, Growing At An 5.03% CAGR – Credence Research
PUNE, India, May 5, 2025 /PRNewswire/ -- The global Digital Wound Management Devices Market was valued at USD 2,415.89 million...
Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors
SAN CARLOS, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines...
Sanara MedTech to Report First Quarter 2025 Financial Results on May 14, 2025
FORT WORTH, TX, April 23, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical...
Recce Pharmaceuticals Receives Approval for Additional Phase II Trial of RECCE® 327 Topical Gel for Diabetic Foot Infections
Human Research Ethics Committee (HREC) approval received to allow up to 20 additional patients access to RECCE® 327 Topical Gel...
Best Berberine Supplement: Top Berberine Supplements For Weight Loss & Blood Sugar From Sugar Defender
Best Berberine Supplement for Weight loss and Blood sugar. It is used for centuries in traditional medicine, berberine is now...
Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors
FLORHAM PARK, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing...
Spectrum Vascular Welcomes New Executive Leadership
WHITE PLAINS, N.Y.--(BUSINESS WIRE)--Spectrum Vascular (“Spectrum” or the “Company”), a provider of vascular access and medication management products designed to...
Microban International Wins Silver Edison Award for Sustainable Antimicrobial Technology Ascera™
HUNTERSVILLE, N.C., April 10, 2025 /PRNewswire/ -- Microban International, the leader in antimicrobial solutions, has been awarded the silver Edison...
Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients
Interim blinded safety and pharmacokinetic data to be presented at the Congress of the European Society of Clinical Microbiology and...
Recce Pharmaceuticals Announces A$5.0 million Placement & Launches A$10.8 million Entitlement Offer to Shareholders
A$5.0 million commitment received from Australian-based private investorA$10.8 million Entitlement Offer at the same offer price as the placementFunds to...
The ‘Father of Modern Food and Drug Law,’ Peter Hutt, Joins EVŌQ Nano Board of Directors
Hutt Brings Decades of Regulatory Insight to Help Advance Nanoparticle Technology Platform SALT LAKE CITY, April 9, 2025 /PRNewswire/ --...
Seegene Announces Development of CURECA™, a Next-Generation Fully Automated PCR Solution Featuring Customizable Pre-treatment Automation
- Seegene to showcase a conceptual video introducing CURECA™ at ESCMID Global 2025 — a full automation system expected to cover the entire...
Cepheid and Oxford Nanopore Technologies Partner to Advance Automated Sequencing-Based Solutions
Collaboration to leverage Oxford Nanopore's sequencing platform and Cepheid's GeneXpert system to advance the field of sequencing for infectious diseases...
Valneva and LimmaTech Announce First Vaccination in Phase 2 Infant Study of Tetravalent Shigella Vaccine Candidate S4V2
Saint Herblain (France) and Schlieren (Zurich), April 9, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine...
FendX Discusses CDC Recent Reports on the Rise of Antimicrobial Resistance
CDC reports antimicrobial resistance is an urgent global public health threat and, in the U.S., more than 2.8 million antimicrobial...
Biotia Announces Collaboration with Mayo Clinic to Advance Microbial Identification for Infectious Disease Diagnostics
NEW YORK, April 2, 2025 /PRNewswire/ -- Biotia today announced a joint development agreement with Mayo Clinic to propel precision medicine in infectious disease diagnostics. This collaboration...
Prime Biome Reviews DON’T SKIP UNTIL SEE THIS for Preventing Fraud and Guaranteeing Reliability!
ST. PETERSBURG, Fla., April 02, 2025 (GLOBE NEWSWIRE) -- 2025, a popular supplement for reviving the gut and skin micro...
Appili President and CEO, Don Cilla to Join Aditxt CEO, Amro Albanna for Aditxt Weekly Update on April 4, 2025
Event exploring the escalating threat of emerging infectious diseases Discussion covering going-private transaction with Aditxt, strategic growth partner HALIFAX, Nova...